Education
About Us
Working with TipRanks
Follow Us
Randal Mills Insider Profile
4 Followers
Randal Mills, President & CEO, Director at Osiris Therapeutics Inc, holds 358.79K shares in Elutia (Ticker: ELUT), holds 247.00K shares in Osiris Therapeutics Inc (Ticker: OSIR). Most recently, Randal Mills Bought ― shares of Elutia on Nov 26, 2025 for an estimated value of $3.00K.
Randal Mills Osiris Therapeutics Inc (OSIR)President & CEO, Director
Osiris Therapeutics Inc (OSIR)
President & CEO, Director
Not Ranked
Randal Mills has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Randal Mills holds in companies
Most Profitable Insider Trade
The most profitable trade made by Randal Mills
Randal Mills's Trading History
Osiris Therapeutics Inc
Jun 07, 2011
―
Uninformative Sell
3.48K
$4.69M
Elutia
Nov 26, 2025
President & CEO, Director
Informative Buy
3.00K
$248.64K
List of latest transactions for each holding click on a transaction to see Randal Mills's performance on stock
You May Also Like
Randal Mills insider profile FAQ
What is the percentage of profitable transactions made by Randal Mills?
The percentage of profitable transactions made by Randal Mills is ―.
What is the average return per transaction made by Randal Mills?
The average return per transaction made by Randal Mills is ―.
What stocks does Randal Mills hold?
Randal Mills holds: OSIR, ELUT stocks.
What was Randal Mills’s latest transaction?
Randal Mills latest transaction was an Informative Buy of $3.00K.
What was Randal Mills's most profitable transaction?
Randal Mills’s most profitable transaction was an Informative Buy of ELUT stock on November 14, 2025. The return on the trade was 0.00%.
What is Randal Mills's role in Osiris Therapeutics Inc?
Randal Mills's role in Osiris Therapeutics Inc is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.